Diabetes-Induced Damages in Rat Kidney and Brain and Protective Effects of Natural Antioxidants

Abstract

Context: In case of diabetes, persistent and chronic hyperglycaemia may generate free radicals and reactive oxygen species (ROS), which trigger an oxidative stress. Garlic (Allium sativum) is a rich source of bioactive compounds and is used in folk medicine for the treatment of various diseases, including diabetes. Besides, α-tocopherol and magnesium have been shown to possess antioxidative properties. Objective: Protective effects of either a garlic aqueous extract or an association of α-tocopherol and magnesium association upon oxidative stress and dysfunctions in kidney and brain of alloxan-diabetic rats were investigated. Results: Both garlic extract and the combination of α-tocopherol and magnesium were found to normalize many parameters which were shifted to pathological values as a consequence of the alloxan-induced diabetes: plasma creatinine and urea levels were decreased, protein leakage in urine was reduced and cortisol level was brought back to control value. In addition, superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX) activities, which were lowered in kidney and brain of diabetic animals, were restored by both treatments and, consequently, level of lipids peroxidation was reduced in these organs, as compared to diabetic animals. Conclusion: Both garlic extract and α-tocopherol + magnesium association display beneficial effects upon nephropathy and oxidative stress in alloxan-diabetic rats. The protective effect of garlic is mainly attributed to antioxidant properties and the presence of phenolic acids and flavonoids.

Share and Cite:

N. Hfaiedh, S. Mbarki, H. Alimi, J. Murat and A. Elfeki, "Diabetes-Induced Damages in Rat Kidney and Brain and Protective Effects of Natural Antioxidants," Food and Nutrition Sciences, Vol. 4 No. 4, 2013, pp. 436-444. doi: 10.4236/fns.2013.44056.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] A. L. McCall, “The Impact of Diabetes on the CNS,” Diabetes, Vol. 41, No. 5, 1992, pp. 557-570. doi:10.2337/diabetes.41.5.557
[2] W. H. Gispen and G. J. Biessels, “Cognition and Synaptic Plasticity in Diabetes Mellitus,” Trends in Neuroscience, Vol. 23, No. 11, 2000, pp. 542-549. doi:10.1016/S0166-2236(00)01656-8
[3] J. H. Hong, M. R. Kim Park, O. G. Kwag, K. B. Lee and S. J. Rhee, “Effects of Vitamin E on Oxidative Stress and Membrane Fluidity in Brain of Streptozotocin-Induced Diabetics Rats,” Clinica Chimica Acta, Vol. 340, No. 1-2, 2004, pp. 107-115. doi:10.1016/j.cccn.2003.10.003
[4] H. Vural, T. Sabuncu, S. O. Arslan and N. Aksoy, “Melatonin Inhibits Lipid Peroxidation and Stimulates the Anti oxidant Enzymes in Colon of Methylazoxymethanol Trea ted Rats,” Clinical Chemistry and Laboratory Medicine, Vol. 8, 2000, pp. 1051-1053.
[5] M. Thomson, Z. M. Al Amin, K. K. Al-Qattan, L. H. Shaban and Ali Muslim, “Anti-Diabetic and Hypolipidaemic Properties of Garlic (Allium Sativum) in Streptozotocin-Induced Diabetic Rats,” International Journal of Diabetes & Metabolism, Vol. 15, 2007, pp. 108-115.
[6] D. Dreher and A. F. Junod, “Role of Oxygen Free Radicals in Cancer Development,” European Journal of Cancer, Vol. 32A, No. 1, 1996, pp. 30-38. doi:10.1016/0959-8049(95)00531-5
[7] H. D. Hammers, S. Martin, K. Fedesrlin, K. Geisen and M. Brownlle, “Aminoguanidine Treatment Inhibit the Development of Complications in Diabetes,” Diabetes, Vol. 40, 1991, pp. 405-412.
[8] G. J. Biesells, A. C. Kapella, B. Bravenboer, D. W. Erkel ens and W. H. Gispen, “Cerebral Function in Diabetes Mellitus,” Diabetologia, Vol. 37, No. 7, 1994, pp. 643-650. doi:10.1007/BF00417687
[9] G. Baydas, H. Canatan and A. Turkoglu, “Comparative Analyses of the Protective Effects of Melatonin and Vitamin E on Streptozotocin-Induced Diabetes Mellitus,” Journal of Pineal Research, Vol. 32, No. 4, 2002, pp. 225-230. doi:10.1034/j.1600-079X.2002.01856.x
[10] R. M. Couch, “Dissociation of Cortisol and Adrenal An drogen Secretion in Poorly Controlled Insulin-Dependent Diabetes Mellitus,” Acta Endocrinologica, Vol. 127, No. 2, 1992, pp. 115-117.
[11] Y. B. Lambardo and A. G. Chicco, “Effects of Dietary Polyunsaturated n-3 Fatty Acids on Dyslipidemia and Insulin Resistance in Rodents and Humans. A Review,” The Journal of Nutritional Biochemestry, Vol. 17, No. 1, 2006, pp. 1-13. doi:10.1016/j.jnutbio.2005.08.002
[12] J. K. Grover, S. Yadav and V. Vats, “Medicinal Plants of India with Anti-Diabetes Potential,” Journal of Ethno pharmacology, Vol. 81, No. 1, 2002, pp. 81-100. doi:10.1016/S0378-8741(02)00059-4
[13] K. T. Augusti and C. G. Sheela, “Antiperoxide Effect of S-Allyl Cysteine Sulfoxide, a Insulin Secretagogue, in Diabetic Rats,” Experientia, Vol. 52, No. 2, 1996, pp. 115-120. doi:10.1007/BF01923354
[14] M. Ali and M. Thomson, “Consumption of a Garlic Clove a Day Could Be Beneficial in Preventing Thrombosis,” Prostaglandins Leukot Essent Fatty Acids, Vol. 53, No. 3, 1995, pp. 211-212. doi:10.1016/0952-3278(95)90118-3
[15] T. Bordia, N. Mohammed, M. Thomson and M. Ali, “An Evaluation of Garlic and Onion as Antithrombotic Agents,” Prostaglandins, Leukotrienes and Essential Fatty Acids, Vol. 54, No. 3, 1996, pp. 183-186. doi:10.1016/S0952-3278(96)90014-9
[16] M. Thomson, T. Mustafa and M. Ali, “Thromboxane-B2 Levels in Serum of Rabbits Receiving a Single Intravenous Dose of Aqueous Extract of Garlic and Onion,” Prostaglandins, Leukotrienes and Essential Fatty Acids, Vol. 63, No. 4, 2000, pp. 217-221. doi:10.1054/plef.2000.0212
[17] M. M. Anwar and A. R. Meki, “Oxidative Stress in Strep tozotocin-Induced Diabetic Rats: Effects of Garlic Oil and Melatonin,” Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, Vol. 135, No. 4, 2003, pp. 539-547. doi:10.1016/S1095-6433(03)00114-4
[18] K. Rahman, “Garlic and Aging: New Insights into an Old Remedy,” Ageing Research Reviews, Vol. 2, No. 1, 2003, pp. 39-56. doi:10.1016/S1568-1637(02)00049-1
[19] M. Ali, K. K. Al-Qattan, F. Al-Enezi, R. M. Khanafer and T. Mustafa, “Effect of Allicin from Garlic Powder on Se rum Lipids and Blood Pressure in Rats Fed with a High Cholesterol Diet,” Prostaglandins, Leukotrienes and Essential Fatty Acids, Vol. 62, No. 4, 2000, pp. 253-259. doi:10.1054/plef.2000.0152
[20] A. Eidi, M. Eidi and E. Esmaeili, “Antidiabetic Effect of Garlic (Allium sativum L.) in Normal and Streptozotocin Induced Diabetic Rats,” Phytomedicine, Vol. 13, No. 9-10, 2006, pp. 624-629. doi:10.1016/j.phymed.2005.09.010
[21] B. B. Whitemore and A. S. Naidu, “Thiosulfinates,” In: A. S. Naidu, Ed., Natural Food Antimicrobial Systems, CRC Press, Boca Raton, 2000, pp. 265-380. doi:10.1201/9781420039368.ch13
[22] J. T. Pinto and R. S. Rivlin, “Antiproliferative Effects of Allium Derivatives from Garlic,” Journal of Nutrition, Vol. 131, No. 3S, 2001, pp. 1058S-1060S.
[23] S. K. Banerjee and S. K. Maulik, “Effect of Garlic on Cardiovascular Disorders: A Review,” Nutrition Journal, 2002, Vol. 1, p. 4. doi:10.1186/1475-2891-1-4
[24] T. Moriguchi, K. Takashina, P. J. Chu, H. Saito and N. Nishiyama, “Prolongation of Life Span and Improved Learning in the Senescence Accelerated Mouse Produced by Aged Garlic Extract,” Biological & Pharmaceutical Bulletin, Vol. 17, No. 12, 1994, pp. 1589-1594.
[25] T. Moriguchi, H. Saito and N. Nishiyama, “Anti-Aging Effect of Aged a Garlic Extract in the Inbred Brain Atrophy Mouse Model,” Clinical and Experimental Pharmacology and Physiology, Vol. 24, No. 3-4, 1997, pp. 235-242. doi:10.1111/j.1440-1681.1997.tb01813.x
[26] O. I. Aruoma, J. P. E. Spencer, D. Warren, P. Jenner, J. Butler and B. Haliwell, “Characterisation of Food Anti oxidants, Illustrated Using Commercial Garlic and Ginger Preparations,” Food Chemistry, Vol. 60, No. 2, 1997, pp. 149-156. doi:10.1016/S0308-8146(95)00254-5
[27] F. Sun, K. Iwaguchi, R. Shudo, Y. Nagaki, K. Tanaka, K. Ikeda, et al., “Change in Tissue Concentrations of Lipid Hydroperoxides, Vitamin C and Vitamin E in Rats with Streptozotocin-Induced Diabetes,” Clinical Science, Vol. 96, 1999, pp. 185-190. doi:10.1042/CS19980189
[28] H. Murase, J. H. Moon, R. Yamauchi, K. Kato, T. Yoshi kawa and J. Terao, “Antioxidant Activity of a Novel Vitamin E Derivative, 2-(Alpha-D-Glucopyranosyl) Methyl 2,5,7,8,-Tetramethylchroman-6-ol,” Free Radical Biology and Medicine, Vol. 24, No. 2, 1998, pp. 217-225. doi:10.1016/S0891-5849(97)00221-9
[29] J. T. Salonen, K. Nyyssonen, T. P. Tuomainen, P. H. Maenpaa, H. Korpela, G. A. Kaplan, et al., “Increased Risk of Noninsulin Dependent Diabetes Mellitus at Low Plasma Vitamin E Concentrations: A Four Year Follow-Up Study in Men,” British Medical Journal, Vol. 311, 1995, pp. 1124-1127. doi:10.1136/bmj.311.7013.1124
[30] R. Andrew, P. Skyrme-Jones, R. C. O’Brien, K. L. Berry and I. T. Meredith, “Vitamin Supplementation Improves Endothelial Function in Type 1 Diabetes Mellitus. A Randomized Placebo-Controlled Study,” Journal of the Ame rican College of Cardiology, Vol. 36, No. 1, 2000, pp. 94-102. doi:10.1016/S0735-1097(00)00720-8
[31] N. E. Saris, E. Mervaala, H. Karppanen, J. A. Khawaja and A. Lewenstam, “Magnesium: An Secretagogue, in Dia betic Rats,” Experientia, Vol. 52, 2000, pp. 115-120.
[32] M. Barbagallo, L. J. Dominguez, A. Galioto, A. Ferlisi, C. Cani, L. Malfa, et al., “Role of Magnesium in Insulin Action, Diabetes and Cardiometabolic Sydrome X,” Molecular Aspects of Medicine, Vol. 24, No. 1-3, 2003, pp. 39-52. doi:10.1016/S0098-2997(02)00090-0
[33] P. J. Lefebvre, G. Paolisso and A. J. Scheen, “Magnesium and Glucose Metabolism,” Therapie, Vol. 49, 1994, pp. 1-7.
[34] W. H. L. Koa, A. R. Folsom, J. F. Nieto, J. P. Mo, R. L. Watson and F. L. Brancati, “Serum and Dietary Magnesium and the Risk for Type 2 Diabetes Mellitus,” Archives of Internal Medicine, Vol. 159, No. 18, 1999, pp. 2151-2159. doi:10.1001/archinte.159.18.2151
[35] K. Kisters, C. Spieker, M. Tepel and W. Zidek, “New Data about the Effect of Oral Physiological Magnesium Supplementation on Several Cardiovascular Risk Factors (Lipids and Blood Pressure),” Magnesium Research, Vol. 6, No. 4, 1993, pp. 355-360.
[36] F. Guerrero-Romero and M. Rodriguez-Moran, “Hypo magnesemia Is Linked to Low Serum HDL-Cholesterol Irrespective of Serum Glucose Values,” Journal of Diabetes and Its Complications, Vol. 14, No. 5, 2000, pp. 272-276. doi:10.1016/S1056-8727(00)00127-6
[37] J. R. White Jr. and R. K. Campbell, “Magnesium and Diabetes: A Review,” The Annals of Pharmacotherapy, Vol. 27, No. 6, 1993, pp. 775-780.
[38] L. Al-Shamaony, S. M. Al-Khazraji and H. A. Twaiji, “Hypoglycaemic Effect of Artemisia herbaalba. II. Ef fect of a Valuable Extract on Some Blood Parameters in Diabetic Animals,” Journal of Ethnopharmacology, Vol. 43, No. 3, 1994, pp. 167-171. doi:10.1016/0378-8741(94)90038-8
[39] M. P. Gupta, N. G. Solis, M. Esposito and S. Sanchez, “Hypoglycemic Activity of Neurolaena lobata (L) R. Br.,” Journal of Ethnopharmacology, Vol. 10, No. 3, 1984, pp. 323-327. doi:10.1016/0378-8741(84)90020-5
[40] M. S. Farvid, F. Siassi, M. Jalali, M. Hosseini and N. Saadat, “The Impact of Vitamin and/or Mineral Supplementation on Lipid Profiles in Type 2 Diabetes,” Diabetes Research and Clinical Practice, Vol. 65, No. 1, 2004, pp. 21-28. doi:10.1016/j.diabres.2003.11.009
[41] N. Aksoy, H. Vural, T. Sabuncu, O. Arslan and S. Aksoy, “Beneficial Effects of Vitamins C and E against Oxidative Stress in Diabetic Rats,” Nutrition Research, Vol. 25, No. 6, 2005, pp. 625-630. doi:10.1016/j.nutres.2005.05.005
[42] K. Yagi, “A Simple Fluorometric Assay for Lipoperoxide in Blood Plasma,” Biochemical Medicine, Vol. 15, No. 2, 1976, pp. 212-216. doi:10.1016/0006-2944(76)90049-1
[43] H. Aebi, “Catalase in Vitro,” Methods in Enzymology, Vol. 105, 1984, pp. 121-126. doi:10.1016/S0076-6879(84)05016-3
[44] Y. Sun, L. W. Oberley and Y. Li, “A Simple Method for Clinical Assay of Superoxide Dismutase,” Clinical Chemistry, Vol. 34, No. 3, 1988, pp. 497-500.
[45] I. Durak, Z. Yurtarslanl, O. Canbolat and O. Akyol, “A Methodological Approach to Superoxide Dismutase (SOD) Activity Assay Based on Inhibition of Nitroblue Teta zolium (NBT) Reduction,” Clinica Chimica Acta, Vol. 214, No. 1, 1993, pp. 103-104. doi:10.1016/0009-8981(93)90307-P
[46] L. Flohe and W. A. Gunzler, “Assays of Glutathione Per oxidase,” Methods in Enzymology, Vol. 105, No. 1, 1984, pp. 114-121. doi:10.1016/S0076-6879(84)05015-1
[47] O. H. Lowry, N. J. Rosebrough, A. L. Farr and R. J. Randall, “Protein Measurement with the Folin Phenol Re agent,” The Journal of Biological Chemistry, Vol. 193, 1951, pp. 265-275.
[48] I. Grzegorczyk, A. Matkowski and H. Wysokinska, “An tioxidant Activity of Extracts from in Vitro Cultures of Salvia officinalis L.,” Food Chemistry, Vol. 104, No. 2, 2007, pp. 536-541. doi:10.1016/j.foodchem.2006.12.003
[49] W. F. Kaene and G. Eknoyan, “Proteinuria, Albuminuria, Risk, Assessment, Detection, Elimination (PARADE): A Position Paper of the National Kidney Foundation,” American Journal of Kidney Diseases, Vol. 33, No. 5, 1999, pp. 1004-1010. doi:10.1016/S0272-6386(99)70442-7
[50] K. A. Greive, T. M. Osicka, L. M. Russo and W. D. Com per, “Nephrotic-Like Proteinuria in Experimental Diabetes,” American Journal of Nephrology, Vol. 23, No. 1, 2003, pp. 38-46. doi:10.1159/000066297
[51] B. N. Ames, R. Cathcart, E. Schwiers, et al., “Uric Acid Provides an Antioxidant Defense in Humans against Oxidant and Radical-Caused Aging and Cancer: A Hypothe sis,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 78, No. 11, 1981, pp. 6858-6862. doi:10.1073/pnas.78.11.6858
[52] F. Regoli and G. W. Winste, “Quantification of Total Oxidant Scavenging Capacity of Antioxidants for Peroxynitrite Peroxyl Radicals and Hydroxyl Radicals,” Toxicology and Applied Pharmacology, Vol. 156, No. 2, 1999, pp. 96-105. doi:10.1006/taap.1999.8637
[53] M. Roy, B. Collier and A. Roy, “Hypothalamic-Pituitary Adrenal Axis Dysregulation among Diabetic Outpatients,” Psychiatry Research, Vol. 31, No. 1, 1990, pp. 31-37.
[54] M. S. Roy, A. Roy, W. T. Gallucci, B. Gollier, K. Young, T. Kamilaris and G. P. Chrousos, “The Ovine Corticotrophin-Releasing Hormone Stimulation Test in Type I Diabetic Patients and Controls: Suggestion of Mild Chro nic Hypercortisolism,” Metabolism, Vol. 42, No. 6, 1993, pp. 696-700. doi:10.1016/0026-0495(93)90235-G
[55] M. S. Bitar, “Glucocorticoid Dynamics and Impaired Wound Healing in Diabetes Mellitus,” The American Journal of Pathology, Vol. 152, No. 2, 1998, pp. 547-553.
[56] F. M. El-Demerdash, M. I. Yousef and N. I. El-Naga, “Biochemical Study on the Hypoglycemic Effects of On ion and Garlic in Alloxan-Induced Diabetics Rats,” Food and Chemical Toxicology, Vol. 43, No. 1, 2005, pp. 57-63. doi:10.1016/j.fct.2004.08.012
[57] S. Kasuga, M. Ushijima, N. Morihara, et al., “Effect of Aged Garlic Extract (AGE) on Hyperglycemia Induced by Immobilisation Stress in Mice,” Nippon Yakurigaku Zasshi, Vol. 114, No. 3, 1999, pp. 191-197. doi:10.1254/fpj.114.191
[58] J. Imai, N. Ide, S. Nagae, T. Moriguchi and Y. Itakura, “Antioxidant and Radical Scavenging Effects of Aged Garlic Extract and Its Constituents,” Planta Medica, Vol. 60, No. 5, 1994, pp. 417-420. doi:10.1055/s-2006-959522
[59] A. Helen, C. R. Rajasree, K. Krishnakumar, K. T. Augusti and P. L. Vijayammal, “Antioxidant Role of Oils Isolated from Garlic (Allium sativum Linn) and Onion (Allium cepa Linn) on Nicotine-Induced Lipid Peroxidation,” Veterinary & Human Toxicology, Vol. 41, No. 5, 1999, pp. 316-319.
[60] V. Vaidya, K. Ingold and D. Pratt, “Garlic: Source of the Ultimate Antioxidants: Sulfenic Acids,” Angewandte Che mie, Vol. 121, No. 1, 2009, pp. 163-166. doi:10.1002/ange.200804560

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.